PSTV insider trading
HealthcarePLUS THERAPEUTICS, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About PLUS THERAPEUTICS, INC.
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is REYOBIQ, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere to treat various solid organ cancers, such as primary and secondary liver cancers by intra-arterial injection. In addition, it develops and commercializes laboratory-developed tests, such as the CNSide Test to identify tumor cells that have metastasized to the central nervous system in patients with carcinomas and melanomas. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Houston, Texas.
Company website: plustherapeutics.com
PSTV insider activity at a glance
FilingIQ has scored 79 insider transactions for PSTV since Jun 22, 2020. The most recent filing in our index is dated Apr 20, 2026.
Across the full history, 51 open-market purchases
and 2 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on PSTV insider trades is 59.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest PSTV Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for PSTV?
- FilingIQ tracks 79 Form 4 insider transactions for PSTV (PLUS THERAPEUTICS, INC.), covering filings from Jun 22, 2020 onwards. 14 of those were filed in the last 90 days.
- Are PSTV insiders net buyers or net sellers?
- Across the full Form 4 history for PSTV, 51 transactions (65%) were open-market purchases and 2 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does PSTV insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is PSTV in?
- PLUS THERAPEUTICS, INC. (PSTV) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $49.09M.
Methodology & sources
Every PSTV insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.